Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nelum Corp

Clinical trials sponsored by Nelum Corp, explained in plain language.

Not yet recruiting 1

New hope for pancreatic cancer: experimental combo targets tough tumors

Disease control Not yet recruiting

This phase 2 study tests whether adding a hedgehog inhibitor (NLM-001) and two immunotherapy drugs (botensilimab and balstilimab) to standard chemotherapy can shrink tumors better than chemotherapy alone in people with advanced pancreatic cancer that hasn't been treated yet. Abou…

Phase: PHASE2 • Sponsor: Nelum Corp • Aim: Disease control

Last updated May 26, 2026 11:30 UTC